PriceTargets.com logo

Halyard Health - HYH Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$57.25 As of 06/29/2018 01:00 AM ET
+0 (0.00%)
Get New Halyard Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HYH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HYH

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Halyard Health in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $57.25.

This chart shows the closing price for HYH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in Halyard Health. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/22/2018Morgan StanleyBoost TargetUnderweight ➝ Underweight$52.00 ➝ $58.00Medium
6/22/2018Stifel NicolausBoost TargetBuy ➝ Buy$58.00 ➝ $67.00Medium
5/3/2018Morgan StanleyBoost TargetUnderweight ➝ Underweight$48.50 ➝ $52.00High
5/3/2018Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$42.00 ➝ $50.00High
5/3/2018Stifel NicolausBoost TargetBuy ➝ Buy$52.00 ➝ $58.00Low
5/3/2018KeyCorpBoost TargetOverweight ➝ Overweight$61.00 ➝ $62.00Low
4/5/2018KeyCorpUpgradeSector Weight ➝ OverweightMedium
(Data available from 3/26/2018 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Halyard Health logo
Avanos Medical, Inc. operates as a medical technology company. It focuses on delivering clinically medical device solutions to improve patients' quality of life. The firm's portfolio of product offerings focuses on respiratory and digestive health, along with surgical and interventional pain management to improve patient outcomes and reduce the cost of care. Its brands include ON-Q, Coolife, Microcuff, MIC-Key, Quilbloc and Home pump. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Read More

Today's Range

Now: $57.25
Low: $56.93
High: $57.91

50 Day Range

MA: N/A

52 Week Range

Now: $57.25
Low: $38.22
High: $61.52

Volume

886,271 shs

Average Volume

438,537 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Halyard Health?

The following Wall Street research analysts have issued research reports on Halyard Health in the last year:
View the latest analyst ratings for HYH.

What is the current price target for Halyard Health?

0 Wall Street analysts have set twelve-month price targets for Halyard Health in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Halyard Health in the next year.
View the latest price targets for HYH.

What is the current consensus analyst rating for Halyard Health?

Halyard Health currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for HYH.

What other companies compete with Halyard Health?

Other companies that are similar to Halyard Health include CollPlant Biotechnologies, 111, Aclarion, Ainos and Alopexx. Learn More about companies similar to Halyard Health.

How do I contact Halyard Health's investor relations team?

Halyard Health's physical mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The medical instruments supplier's listed phone number is (844) 428-2667 and its investor relations email address is [email protected] The official website for Halyard Health is www.halyardhealth.com. Learn More about contacing Halyard Health investor relations.